Beruflich Dokumente
Kultur Dokumente
2
Infective
Non-STI
STI
Non-infective
Vaginal Discharge
3
Trends in Endocrinology & Metabolism, July 2016, Vol. 27, No. 7
4
Vaginal Infectious Disease in
Different Flora Types
Best Practice & Research Clinical Obstetrics and Gynaecology Vol. 21,
No. 3, pp. 355373, 2007 5
Vaginal Infection
70%
6
7
8
Metronidazole
Tinidazole
Clindamycin
Azole (clotrimazole, miconazole, fluconazole, itraconazole)
Doxycycline
Azithromycin
Erythromycin
Ceftriaxone
Cefixime
Ciprofloxacin
Ofloxacin
9
10
(Algorithms for Obstetrics and Gynaecology, 2014)
11
Local vs systemic route
Significant proportion of
patients do not achieve an
adequate response
Recurrence of BV/ VVC
frequently occurs
Drug resistance may develop
Risk of post-treatment
candidiasis How to improve?
12
Anaerobic gram-negative rod resistant
13
14
15
16
Estimated 2.5 to 5 ml
10 mg of vaginal fluid
vaginal (4000-2000 mg/l)
17
In vitro antimicrobial activity of DQC
18
Arch Gynecol Obstet (2016) 293:469484
MIC of a. vaginae (different strains) for
DQC, clindamycin and metronidazole
19
Dequalinium chloride 10 mg Povidone iodine 200 mg
20
DQC
21
Incidence of post-treatment
BV Clinical cure rate symptomatic and culture-positive VVC
DQC DQC
22
Local tolerance (ADRs 2,4-7,8%)
Pregnant women (No ADRs, 1st
trimester use)
Minimal vaginal absorption
23
From a clinical point of view DQC could
offer an attractive treatment for vaginal
infections, both for BV and VVC as well as
in case of mixed infections
Thank you
24